US Patent 10058613 Pyrrolobenzodiazepine antibody drug conjugates and methods of use
Patent 10058613 was granted and assigned to Genentech on August, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+259 characters)
Article
Patent abstract
The invention provides antibody-drug conjugates comprising an antibody conjugated to a pyrrolobenzodiazepine drug moiety via a disulfide linker, pyrrolobenzodiazepine linker-drug intermediates, and methods of using the antibody-drug conjugates.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
BinQing Wei0
Jack Sadowsky0
Mark X. Sliwkowski0
Peter Dragovich0
Thomas Pillow0
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 5 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 3 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 21 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10058613 Pyrrolobenzodiazepine antibody drug conjugates and methods of use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10058613
Date of patent
August 28, 2018
Patent application number
15281830
Date Filed
September 30, 2016
Patent primary examiner
Find more entities like US Patent 10058613 Pyrrolobenzodiazepine antibody drug conjugates and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
